References
- Benjamini, Y., Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57:289–300.
- Berger, J. O., Wang, X., Shen, L. (2014). A Bayesian approach to subgroup identification. J Biopharm Stat 24:110–129.
- Cai, T., Tian, L., Wong, P. H., Wei, L. J. (2011). Analysis of randomized comparative clinical trial data for personalized treatment selections. Biostatistics 12:270–282.
- Carlin, B. P., Gelfand, A. E. (1990). Approaches for empirical Bayes confidence intervals. Journal of the American Statistical Association 85:105–114.
- Davidoff, F. (2009). Heterogeneity is not always noise: Lessons from improvement. The Journal of the American Medical Association 302:2580–2586.
- Davis, C. E., Leffingwell, D. P. (1990). Empirical Bayes estimates of subgroup effects in clinical trials. Control Clin Trials 11:37–42.
- Dixon, D. O., Simon, R. (1991). Bayesian subset analysis. Biometrics 47:871–881.
- Efron, B. (1987). Empirical Bayes confidence intervals based on bootstrap samples: Comment. Journal of the American Statistical Association 82:754.
- Efron, B. (1996). Empirical Bayes methods for combining likelihoods. Journal of the American Statistical Association 91:538–550.
- Efron, B. (2010a). The future of indirect evidence. Statistical Science 25:145–157.
- Efron, B. (2010b). Large-Scale Inference: Empirical Bayes Methods for Estimation, Testing, and Prediction. Cambridge, UK: Cambridge University Press.
- Efron, B. (2011). Tweedie’s formula and selection bias. Journal of the American Statistical Association 106:1602–1614.
- Efron, B. (2012). A 250-year argument: Belief, behavior, and the bootstrap. Bulletin of the American Mathematical Society 50:129–146.
- Foster, J. C., Taylor, J. M., Ruberg, S. J. (2011). Subgroup identification from randomized clinical trial data. Statistics in Medicine 30:2867–2880.
- Jones, H. E., Ohlssen, D. I., Neuenschwander, B., Racine, A., Branson, M. (2011). Bayesian models for subgroup analysis in clinical trials. Clinical Trials 8:129–143.
- Kent, D. M., Hayward, R. A. (2007). Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. The Journal of the American Medical Association 298:1209–1212.
- Lipkovich, I., Dmitrienko, A., Denne, J., Enas, G. (2011). Subgroup identification based on differential effect search—A recursive partitioning method for establishing response to treatment in patient subpopulations. Statistics in Medicine 30:2601–2621.
- Louis, T. A. (1984). Estimating a population of parameter values using Bayes and empirical Bayes methods. Journal of the American Statistical Association 79:393–398.
- Magnesium in Coronaries (MAGIC) Trial Investigators. (2002). Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: A randomised controlled trial. Lancet 360:1189–1196.
- Morris, C. N. (1983). Parametric empirical Bayes inference: Theory and applications. Journal of the American Statistical Association 78:47–59.
- Qian, M., Murphy, S. A. (2011). Performance guarantees for individualized treatment rules. The Annals of Statistics 39:1180–1210.
- Rubin, D. B. (1984). Bayesianly justifiable and relevant frequency calculations for the applied statisticia. The Annals of Statistics 12:1151–1172.
- Wang, R., Lagakos, S. W., Ware, J. H., Hunter, D. J., Drazen, J. M. (2007). Statistics in medicine—Reporting of subgroup analyses in clinical trials. The New England Journal of Medicine 357:2189–2194.
- Zhao, L., Tian, L., Cai, T., Claggett, B., Wei, L. J. (2013). Effectively selecting a target population for a future comparative study. Journal of the American Statistical Association 108:527–539.
- Zhao, Y., Zeng, D., Rush, A. J., Kosorok, M. R. (2012). Estimating individualized treatment rules using outcome weighted learning. Journal of the American Statistical Association 107:1106–1118.